Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Sells DNA Analysis System to Harvard Cancer Center

NEW YORK, Nov. 21, 2000 – Pyrosequencing of Uppsala, Sweden announced Tuesday it had sold its PSQ 96 DNA sequencing system to the Harvard Center for Cancer Prevention.

Harvard will use the system, which sells for $89,000 , to analyze genetic variations in sample populations and compare this information with known risk factors for colon cancer, breast cancer, and other diseases.

The PSQ 96 operates on a proprietary    “sequencing-by-synthesis” technology, which uses a luciferase light-generating reaction to map sequences in minutes. Researchers can use it for rapid SNP analysis Tag sequencing.

" We are delighted that Harvard Center for Cancer Prevention has chosen our PSQ 96 System to advance their research in cancer and other important diseases," said Pyrosequencing CEO Erik Wallden. " Our instruments and reagents continue to gain broad acceptance among the world's leading academic institutions and we believe that our approach will be the new standard in applied genetic analysis."

Pyrosequencing has also sold its PSQ 96 to Sweden's Karolinska Institute, the National Institutes of Health, the National Cancer Center of Tokyo, and the University of California at Davis.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.